Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer.
Lundberg A, Zhang M, Aggarwal R, Li H, Zhang L, Foye A, Sjöström M, Chou J, Chang K, Moreno-Rodriguez T, Shrestha R, Baskin A, Zhu X, Weinstein AS, Younger N, Alumkal JJ, Beer TM, Chi KN, Evans CP, Gleave M, Lara PN, Reiter RE, Rettig MB, Witte ON, Wyatt AW, Feng FY, Small EJ, Quigley DA. Lundberg A, et al. Among authors: reiter re. Cancer Res. 2023 Aug 15;83(16):2763-2774. doi: 10.1158/0008-5472.CAN-23-0593. Cancer Res. 2023. PMID: 37289025 Free PMC article.
Target antigens for prostate cancer immunotherapy.
Saffran DC, Reiter RE, Jakobovits A, Witte ON. Saffran DC, et al. Among authors: reiter re. Cancer Metastasis Rev. 1999;18(4):437-49. doi: 10.1023/a:1006333222424. Cancer Metastasis Rev. 1999. PMID: 10855787 Review.
Molecular markers and prostate cancer prognosis.
Chin JL, Reiter RE. Chin JL, et al. Among authors: reiter re. Clin Prostate Cancer. 2004 Dec;3(3):157-64. doi: 10.3816/cgc.2004.n.026. Clin Prostate Cancer. 2004. PMID: 15636682 Review.
227 results